Summary
Eight patients were given flunitrazepam 2 mg orally, once daily for 28 consecutive days. The time-course of the plasma concentration of unchanged flunitrazepam and its principal metabolites were studied in detail after the first and last doses. Additional blood samples were collected immediately before administration of the tablet on days 4, 7, 11, 14, 18, 21 and 25. Clinically there were no changes during the trial period in the onset of sleep, duration of sleep, depth of sleep measured as number of spontaneous awakenings, or in the patients' condition on awakening. The time-course of the plasma concentration of flunitrazepam could be described by a three-compartment model, assuming that the rate constants remained unchanged during treatment. Maximal plasma concentrations of unchanged flunitrazepam, found two hours after intake, reached 10–15 ng/ml after the first and 15–20 ng/ml after the last dose. The β-half-life was found to be between 20 and 36 h.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvan, G., Ericsson, O., Levander, S., Lindgren, J.-E.: Plasma concentrations and effects of methaqualone after single and multiple oral doses in man. Eur. J. Clin. Pharmacol.7, 449–454 (1974)
Amrein, R., Cano, J. P., Hügin, W.: Pharmakokinetische und pharmakodynamische Befunde nach einmaliger intravenöser, intramuskulärer und oraler Applikation von Rohypnol. In: Bisherige Erfahrungen mit ‘Rohypnol’ (Flunitrazepam) in der Anästhesiologie und Intensivtherapie. W. Hügin, G. Hossli, M. Gemperle (eds.), pp. 39–56. Basel: Editiones Roche 1976
Cano, J. P., Guintrand, J., Aubert, C., Viala, A.: Determination of flunitrazepam of desmethyl-flunitrazepam and clonazepam in plasma by gas liquid chromatography with an internal standard. Arzneim. Forsch.27, 338–342 (1977)
Cano, J. P., Soliva, M., Hartmann, D., Ziegler, W. H., Amrein, R.: Bioavailability from various galenic formulations of Rohypnol. Arzneim. Forsch.27, 2383–2388 (1977)
Deweer, E.: L'insomniaque sévère et chronique peut-il échapper au barbituriques? Bruxelles-Med.55, 141–146 (1975)
Haefelfinger, P.: Determination of nanogram amounts of primary aromatic amines and nitro compounds in blood and plasma. J. Chromatogr.111, 323–329 (1975)
Haefely, W., Cumin, R., Kulcsar, A., Polc, P., Schaffner, R.: Einige Aspekte der Pharmakologie von Flunitrazepam (‘Rohypnol’). In: Bisherige Erfahrungen mit ‘Rohypnol’ (Flunitrazepam) in der Anästhesiologie und Intensivtherapie. W. Hügin, G. Hossli, M. Gemperle (eds.), pp. 13–26. Basel: Editiones Roche 1976
Hügin, W., Hossli, G., Gemperle, M.: Bisherige Erfahrungen mit ‘Rohypnol’ (Flunitrazepam) in der Anästhesiologie und Intensivtherapie, Symposiumsband. Basel: Editiones Roche 1976
Metzler, C. M.: Nonlin. A computer program for parameter estimation in nonlinear situation. Kalamazoo: The Upjohn Company 1969
Piret, R., Devoghel, J. C.: A double-blind clinical trial of a new benzodiazepine, flunitrazepam as a hypnotic agent. J. Int. Med. Res.2, 370–373 (1974)
Wendt, G.: Schicksal des Hypnotikums Flunitrazepam im menschlichen Organismus. In: Bisherige Erfahrungen mit ‘Rohypnol’ (Flunitrazepam) in der Anästhesiologie und Intensivtherapie. W. Hügin, G. Hossli, M. Gemperle (eds.), pp. 27–38. Basel: Editiones Roche 1976
Wickstrøm, E.: Double-blind study of flunitrazepam (Ro 5-4200) and Mandrax. Anaesthesist23, 90–92 (1974)
Wickstrøm, E.: Clinical trials of flunitrazepam (Ro 5-4200), a new hypnotic, in comparison with allypropymal (aprobarbital), methaqualone diphenhydramine, nitrazepam and placebo. Lecture to 11th Congress of the Scandinavian Society of Anaesthesiologist, Reykjavik. 2–6. 7. 1973
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wickstrøm, E., Amrein, R., Haefelfinger, P. et al. Pharmacokinetic and clinical observations on prolonged administration of flunitrazepam. Eur J Clin Pharmacol 17, 189–196 (1980). https://doi.org/10.1007/BF00561899
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561899